166 related articles for article (PubMed ID: 14690593)
1. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor.
Hu J; Liu J; Ghirlando R; Saltiel AR; Hubbard SR
Mol Cell; 2003 Dec; 12(6):1379-89. PubMed ID: 14690593
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
Stein EG; Ghirlando R; Hubbard SR
J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
Hu J; Hubbard SR
J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
[TBL] [Abstract][Full Text] [Related]
4. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
Ahmed Z; Pillay TS
Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for phosphotyrosine recognition by the Src homology-2 domains of the adapter proteins SH2-B and APS.
Hu J; Hubbard SR
J Mol Biol; 2006 Aug; 361(1):69-79. PubMed ID: 16824542
[TBL] [Abstract][Full Text] [Related]
6. APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase.
Ahmed Z; Smith BJ; Kotani K; Wilden P; Pillay TS
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):665-8. PubMed ID: 10417330
[TBL] [Abstract][Full Text] [Related]
7. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
8. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
10. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl.
Wakioka T; Sasaki A; Mitsui K; Yokouchi M; Inoue A; Komiya S; Yoshimura A
Leukemia; 1999 May; 13(5):760-7. PubMed ID: 10374881
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
12. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
He W; Rose DW; Olefsky JM; Gustafson TA
J Biol Chem; 1998 Mar; 273(12):6860-7. PubMed ID: 9506989
[TBL] [Abstract][Full Text] [Related]
13. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation.
Yokouchi M; Suzuki R; Masuhara M; Komiya S; Inoue A; Yoshimura A
Oncogene; 1997 Jul; 15(1):7-15. PubMed ID: 9233773
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.
Depetris RS; Hu J; Gimpelevich I; Holt LJ; Daly RJ; Hubbard SR
Mol Cell; 2005 Oct; 20(2):325-33. PubMed ID: 16246733
[TBL] [Abstract][Full Text] [Related]
16. Functional effects of APS and SH2-B on insulin receptor signalling.
Ahmed Z; Pillay TS
Biochem Soc Trans; 2001 Aug; 29(Pt 4):529-34. PubMed ID: 11498022
[TBL] [Abstract][Full Text] [Related]
17. SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.
Kotani K; Wilden P; Pillay TS
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):103-9. PubMed ID: 9742218
[TBL] [Abstract][Full Text] [Related]
18. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.
Nelms K; O'Neill TJ; Li S; Hubbard SR; Gustafson TA; Paul WE
Mamm Genome; 1999 Dec; 10(12):1160-7. PubMed ID: 10594240
[TBL] [Abstract][Full Text] [Related]
20. Identification of the APS protein as a novel insulin receptor substrate.
Moodie SA; Alleman-Sposeto J; Gustafson TA
J Biol Chem; 1999 Apr; 274(16):11186-93. PubMed ID: 10196204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
